BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Eli Lilly Acquires Disarm Therapeutics in an Effort to Solve Axonal Degeneration

  Eli Lilly is betting on a new approach to axonal degeneration, announcing a definitive agreement to acquire Disarm Therapeutics, a privately-held biotech company committed to solving this mystery.

  October 15, 2020

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Business

  BioSpace Movers & Shakers, Oct. 16

  Biopharma and life sciences companies bolster their leadership teams with these Movers & Shakers.

  October 15, 2020

   · 

  7 min read

   · 

  Alex Keown
• 

  Genetown

  Moderna Works With International Regulators to Speed Up COVID-19 Vaccine Review Process

  Moderna is working with international regulators to accelerate approval of the company’s COVID-19 vaccine candidate, mRNA-1273.

  October 15, 2020

   · 

  3 min read

   · 

  Brandon May
• 

  BioCapital

  Research Roundup: COVID-19 Neurological Damage and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  October 15, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Biotech Beach

  Biopharma Money on the Move: October 7-14

  Find out which life sciences companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.

  October 15, 2020

   · 

  6 min read

   · 

  Kate Goodwin
• 

  Deals

  A Year After Parntering with iota, Astellas Snaps Up the Company

  Astellas Pharma is building on a 2019 collaborative relationship and snapping up California-based iota Biosciences and that company’s bioelectronics technology in order to accelerate its Rx+ business.

  October 15, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Vertex Abandons VX-814 Program for Treating Rare Liver Disease

  Vertex Pharmaceuticals announced that after early data on its Phase II trial of VX-814 in Alpha-1 antitrypsin deficiency (AATD), it is halting the trial and ending development of the drug.

  October 15, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  Regeneron’s Inmazeb Becomes First Ebola Treatment Approved by FDA

  Regeneron announced that the U.S. Food and Drug Administration approved Inmazeb, a three-antibody cocktail to treat Ebola infections in adults and children.

  October 15, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Legal Team for Elizabeth Holmes Fails in Bid to Dismiss Criminal Charges

  This week, the judge overseeing her trial denied all efforts from her legal team to dismiss more than a dozen criminal charges against the Theranos founder.

  October 15, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Merck Plans New Facility to Triple Production of Life-Saving Bladder Cancer Drug

  The pharma giant is currently the only manufacturer of the bladder cancer treatment for the U.S. and Europe.

  October 15, 2020

   · 

  2 min read

   · 

  Kate Goodwin